Editors' ChoiceCancer An epigenetic tactic to treat RMS Leslie K. FerrarelliScience Signaling, AAAS, Washington, DC 20005, USA See allHide authors and affiliations Science Signaling 29 Aug 2017:Vol. 10, Issue 494, eaap7466DOI: 10.1126/scisignal.aap7466 Leslie K. Ferrarelli , AAAS, Washington, DC 20005, USAFind this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters Article Information vol. 10 no. 494 DOI: https://doi.org/10.1126/scisignal.aap7466 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: Copyright © 2017, American Association for the Advancement of Science Author Information Leslie K. FerrarelliScience Signaling, AAAS, Washington, DC 20005, USA Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2017 to January 2021 AbstractFullPdf Aug 201712073320 Sep 201714544010 Oct 201744420 Nov 201748200 Dec 201732110 Jan 201840140 Feb 201843100 Mar 201832130 Apr 201825120 May 201832150 Jun 201814140 Jul 20189120 Aug 20180220 Sep 20182140 Oct 20180260 Nov 20180180 Dec 20180310 Jan 20192280 Feb 20192220 Mar 20192190 Apr 20190120 May 20194200 Jun 20191140 Jul 20191110 Aug 20190230 Sep 2019180 Oct 20191170 Nov 2019380 Dec 2019070 Jan 2020080 Feb 20200100 Mar 2020080 Apr 20201130 May 2020040 Jun 20201120 Jul 20200100 Aug 2020180 Sep 2020090 Oct 20200150 Nov 20200180 Dec 20204150 Jan 2021040 View Full Text
An epigenetic tactic to treat RMS By Leslie K. Ferrarelli Science Signaling29 Aug 2017 BET inhibitors may be an effective treatment for some rhabdomyosarcomas.
An epigenetic tactic to treat RMS By Leslie K. Ferrarelli Science Signaling29 Aug 2017 BET inhibitors may be an effective treatment for some rhabdomyosarcomas.